Study to Evaluate the Real-World Effectiveness, Safety and Tolerability of Treatment With Apremilast in Psoriatic Arthritis Patients Followed in Canadian Routine Care (APPRAISE)
Clinical trial NCT03608657 · COMPLETED
Trial details
- NCT number
- NCT03608657
- Sponsor
- Amgen
- Status
- COMPLETED
- Study type
- OBSERVATIONAL
- Start date
- 2018-07-31
- Primary completion
- 2021-04-12
- Enrollment
- 102
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.